Daptomycin Dosing in Hemodialysis
For your 85 kg patient on hemodialysis, administer daptomycin 510 mg (6 mg/kg) intravenously after each hemodialysis session, three times weekly.
Dosing Rationale
The FDA label explicitly states that daptomycin requires dosage interval modification for patients with creatinine clearance <30 mL/min, including those on hemodialysis 1. The key principle is that daptomycin is significantly removed by hemodialysis (approximately 50-58% reduction during a 4-hour session with high-flux membranes) 1, 2.
Standard Dosing Framework
The appropriate dose depends on your indication:
- For complicated skin/soft tissue infections: 4 mg/kg = 340 mg per dose
- For bacteremia or endocarditis: 6 mg/kg = 510 mg per dose 3
Most clinicians treating serious MRSA infections in dialysis patients use 6 mg/kg given the severity of infections in this population.
Timing and Frequency
Administer post-hemodialysis, three times weekly (coinciding with dialysis days). This approach is supported by multiple pharmacokinetic studies showing:
- Daptomycin half-life in hemodialysis patients is 19-28 hours off dialysis and only 3.8 hours during dialysis 2, 4
- Post-dialysis dosing maintains therapeutic concentrations throughout 48-hour interdialytic periods 2, 4
- Steady-state is achieved by day 5 with this regimen 4
Critical Adjustment for 72-Hour Period
For the longer interdialytic interval (typically Friday to Monday in thrice-weekly schedules), you must increase the dose by 50% to maintain adequate drug levels. For your patient:
- Standard 48-hour intervals: 510 mg
- Before 72-hour interval: 765 mg (510 mg × 1.5)
This adjustment is necessary because pharmacokinetic modeling demonstrates that standard dosing results in subtherapeutic AUC values during the 48-72 hour period 5.
Monitoring Requirements
Monitor creatine phosphokinase (CPK) more frequently than weekly in hemodialysis patients 1. The FDA label specifically emphasizes this for patients with renal impairment because:
- Daptomycin accumulation risk is higher
- Trough concentrations ≥24.3 mg/L correlate with increased muscular toxicity risk 5
- One pharmacokinetic study showed higher probability of elevated troughs in certain hemodialysis populations 5
Check CPK at baseline, then at least twice weekly during therapy, and immediately if the patient develops muscle pain, weakness, or dark urine.
Practical Implementation
- Calculate exact dose: 85 kg × 6 mg/kg = 510 mg
- Reconstitute with 0.9% sodium chloride 1
- Infuse over 30 minutes post-dialysis 1, 2
- Schedule: Monday/Wednesday/Friday pattern
- Monday: 510 mg
- Wednesday: 510 mg
- Friday: 765 mg (before 72-hour gap)
Common Pitfalls to Avoid
- Do not dose every 48 hours as the package insert suggests—this creates dyssynchrony with thrice-weekly dialysis schedules and complicates medication administration 6
- Do not give pre-dialysis—approximately 50% will be removed during the session, resulting in subtherapeutic levels 2
- Do not use weight-based dosing alone without renal adjustment—this ignores the profound impact of dialysis on drug clearance 1
- Do not forget the 50% dose increase before the 72-hour interdialytic period—standard dosing leaves patients undertreated for 24+ hours 5
The evidence strongly supports this thrice-weekly, post-dialysis approach with dose augmentation before longer intervals as both safe and effective, with pharmacokinetic parameters demonstrating adequate target attainment even for organisms with MIC₉₀ values typical of S. aureus and Enterococcus 2, 4, 5.